Will a BLA for the skin cancer vaccine be submitted by...?
Market Rules
This event predicts whether it is officially announced that a Biologics License Application (BLA) for intismeran autogene (mRNA-4157/V940) has been submitted to, or accepted for review by, the FDA by each of the dates below, 11:59 PM ET. Each market covers one deadline and resolves independently; an FDA approval by a deadline also resolves that market to "Yes". Resolution is based on official communications from the submitting company or the FDA, and a consensus of credible reporting may also be used.